Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function
The Canadian Journal of Psychiatry · 2023-05 · 68 (5) · 347-358
DOI: 10.1177/07067437221147443 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Canadian Journal of Psychiatry, online erschienen am 13.01.2023. Verfasst von Daniel Kapustin und 45 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Alzheimer Disease. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Neuropsychiatric symptoms (NPS) are prevalent in neurodegenerative disorders, however, their frequency and impact on function across different disorders is not well understood. We compared the frequency and severity of NPS across Alzheimer's disease (AD) (either with mild cognitive impairment or dementia), Cerebrovascular disease (CVD), Parkinson's disease (PD), frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), and explored the association between NPS burden and function.
Methods
We obtained data from Ontario Neurodegenerative Disease Research Initiative (ONDRI) that included following cohorts: AD ( N = 111), CVD ( N = 148), PD ( N = 136), FTD ( N = 50) and ALS ( N = 36). We compared the frequency and severity of individual NPS (assessed by the neuropsychiatric inventory questionnaire) across cohorts using generalized estimating equations and analysis of variance. Second, we assessed the relationship of NPS burden with instrumental (iADLs) and basic (ADLs) activities of living across cohorts using multivariate linear regression while adjusting for relevant demographic and clinical covariates.
Results
Frequency of NPS varied across cohorts (χ 2 (4) = 34.4, p < .001), with post-hoc tests showing that FTD had the greatest frequency as compared to all other cohorts. The FTD cohort also had the greatest severity of NPS ( H (4) = 34.5, p < .001). Further, there were differences among cohorts in terms of the association between NPS burden and ADLs ( F (4,461) = 3.1, p = 0.02). Post-hoc comparisons suggested that this finding was driven by the FTD group, however, the differences did not remain significant following Bonferroni correction. There were no differences among cohorts in terms of the association between NPS burden and IADLs.
Conclusions
NPS frequency and severity are markedly greater in FTD as compared to other neurodegenerative diseases. Further, NPS burden appears to be associated differently with function across neurodegenerative disorders, highlighting the need for individualized clinical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
- Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
- Rotman Research Institute at Baycrest Health Sciences, Toronto, ON, Canada.
- Nova Scotia Health, Halifax, Nova Scotia, Canada.
- Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
ORCID-Profile: Daniel Kapustin, Wei Wang
Zitieren
APA
Kapustin, D., Zarei, S., Wang, W., Binns, M. A., McLaughlin, P. M., Abrahao, A., Black, S. E., Borrie, M., Breen, D., Casaubon, L., Dowlatshahi, D., Finger, E., Fischer, C. E., Frank, A., Freedman, M., Grimes, D., Hassan, A., Jog, M., Kwan, D., …, & Kumar, S. (2023). Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function. The Canadian Journal of Psychiatry, 68(5), 347-358. https://doi.org/10.1177/07067437221147443
Vancouver
Kapustin D, Zarei S, Wang W, Binns MA, McLaughlin PM, Abrahao A, et al. Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function. The Canadian Journal of Psychiatry. 2023;68(5):347-358. doi:10.1177/07067437221147443
BibTeX
@article{Kapustin2023,
author = {Kapustin, Daniel and Zarei, Shadi and Wang, Wei and Binns, Malcolm A and McLaughlin, Paula M and Abrahao, Agessandro and Black, Sandra E and Borrie, Michael and Breen, David and Casaubon, Leanna and Dowlatshahi, Dar and Finger, Elizabeth and Fischer, Corinne E and Frank, Andrew and Freedman, Morris and Grimes, David and Hassan, Ayman and Jog, Mandar and Kwan, Donna and Lang, Anthony and Levine, Brian and Mandzia, Jennifer and Marras, Connie and Masellis, Mario and Orange, Joseph B and Pasternak, Stephen and Peltsch, Alicia and Pollock, Bruce G and Rajji, Tarek K and Roberts, Angela and Sahlas, Demetrios and Saposnik, Gustavo and Seitz, Dallas and Shoesmith, Christen and Southwell, Alisia and Steeves, Thomas D L and Sunderland, Kelly and Swartz, Richard H and Tan, Brian and Tang-Wai, David F and Tartaglia, Maria Carmela and Troyer, Angela and Turnbull, John and Zinman, Lorne and ONDRI investigators, ONDRI investigators and Kumar, Sanjeev},
title = {Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function},
journal = {The Canadian Journal of Psychiatry},
year = {2023},
volume = {68},
number = {5},
pages = {347--358},
doi = {10.1177/07067437221147443}
}
EUVIMED